Renibus Therapeutics Inc Is A Clinical Stage Biopharmaceutical Company Based In Southlaketexasthe Company Is Dedicated To Developing Therapies Aimed At Preventing Disease Progression And Improving Patient Outcomes In Cardiorenal And Metabolic Diseasesrenibus Focuses On Addressing Unmet Medical Needs With Its Pipeline Of Innovative Productsincluding First In Class And Breakthrough Designated Therapies The Company S Lead Productrbt 1Is An Intravenous Drug Designed To Reduce Postoperative Complications In Cardiothoracic Surgery Patients And Is Currently In Phase 3 Trialsanother Key Productveverimeris An Oral Hydrochloric Acid Binder Targeting Rare Gastrointestinal Acid Related Disordersrenibus Also Has Three Early Stage Candidates In Developmentthe Company Has Secured Significant Funding To Advance Its Clinical Trials And Has Established Partnerships To Support Its Financial And Operational Goals
